Free Trial
NASDAQ:SGRY

Surgery Partners (SGRY) Stock Price, News & Analysis

Surgery Partners logo
$22.04 -0.23 (-1.03%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$22.04 +0.01 (+0.02%)
As of 07/11/2025 05:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Surgery Partners Stock (NASDAQ:SGRY)

Key Stats

Today's Range
$21.93
$22.26
50-Day Range
$19.30
$23.94
52-Week Range
$18.87
$33.97
Volume
793,153 shs
Average Volume
1.21 million shs
Market Capitalization
$2.82 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$33.56
Consensus Rating
Moderate Buy

Company Overview

Surgery Partners Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
49th Percentile Overall Score

SGRY MarketRank™: 

Surgery Partners scored higher than 49% of companies evaluated by MarketBeat, and ranked 658th out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Surgery Partners has received a consensus rating of Moderate Buy. The company's average rating score is 2.70, and is based on 7 buy ratings, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Surgery Partners has only been the subject of 2 research reports in the past 90 days.

  • Read more about Surgery Partners' stock forecast and price target.
  • Earnings Growth

    Earnings for Surgery Partners are expected to grow by 20.90% in the coming year, from $0.67 to $0.81 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Surgery Partners is -14.41, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Surgery Partners is -14.41, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Surgery Partners has a P/B Ratio of 0.88. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Surgery Partners' valuation and earnings.
  • Percentage of Shares Shorted

    15.07% of the float of Surgery Partners has been sold short.
  • Short Interest Ratio / Days to Cover

    Surgery Partners has a short interest ratio ("days to cover") of 7.9.
  • Change versus previous month

    Short interest in Surgery Partners has recently increased by 21.47%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Surgery Partners does not currently pay a dividend.

  • Dividend Growth

    Surgery Partners does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    15.07% of the float of Surgery Partners has been sold short.
  • Short Interest Ratio / Days to Cover

    Surgery Partners has a short interest ratio ("days to cover") of 7.9.
  • Change versus previous month

    Short interest in Surgery Partners has recently increased by 21.47%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Surgery Partners has a news sentiment score of 0.62. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.00 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Surgery Partners this week, compared to 5 articles on an average week.
  • Search Interest

    1 people have searched for SGRY on MarketBeat in the last 30 days.
Receive SGRY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Surgery Partners and its competitors with MarketBeat's FREE daily newsletter.

SGRY Stock News Headlines

Gold is soaring. Here’s how to get paid from it
Gold just broke through $3,300… And while the headlines shout about price targets, something even more powerful is happening behind the scenes… Some investors are using a little-known ETF to collect up to $1,152/month from gold's surge. No trading gold futures. No mining stocks. No vaults. Just a simple fund delivering monthly payouts — like clockwork.
SGRY Surgery Partners, Inc. - Seeking Alpha
See More Headlines

SGRY Stock Analysis - Frequently Asked Questions

Surgery Partners' stock was trading at $21.17 on January 1st, 2025. Since then, SGRY shares have increased by 4.1% and is now trading at $22.04.

Surgery Partners, Inc. (NASDAQ:SGRY) announced its quarterly earnings data on Monday, May, 12th. The company reported $0.04 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.08 by $0.04. The firm's quarterly revenue was up 8.2% on a year-over-year basis.
Read the conference call transcript
.

Top institutional investors of Surgery Partners include E. Ohman J or Asset Management AB (0.75%) and Wesbanco Bank Inc. (0.09%). Insiders that own company stock include Andrew T Kaplan, Jason Eric Evans, David T Doherty, Jennifer Baldock, Wayne S Deveydt, Harrison R Bane, Bradley R Owens, Marissa Brittenham, William Trenton Webb, Brent Turner, Laura L Brocklehurst and Danielle Burkhalter.
View institutional ownership trends
.

Shares of SGRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Surgery Partners investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), Palo Alto Networks (PANW), ServiceNow (NOW) and Adobe (ADBE).

Company Calendar

Last Earnings
5/12/2025
Today
7/11/2025
Next Earnings (Estimated)
8/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Services
Sub-Industry
Healthcare
Current Symbol
NASDAQ:SGRY
CIK
1638833
Employees
15,000
Year Founded
N/A

Price Target and Rating

High Price Target
$43.00
Low Price Target
$24.00
Potential Upside/Downside
+52.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.70
Research Coverage
10 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.53)
Trailing P/E Ratio
37.12
Forward P/E Ratio
32.90
P/E Growth
N/A
Net Income
-$168.10 million
Net Margins
-6.10%
Pretax Margin
3.72%
Return on Equity
2.41%
Return on Assets
0.99%

Debt

Debt-to-Equity Ratio
1.09
Current Ratio
1.89
Quick Ratio
1.73

Sales & Book Value

Annual Sales
$3.11 billion
Price / Sales
0.91
Cash Flow
$1.85 per share
Price / Cash Flow
11.89
Book Value
$25.15 per share
Price / Book
0.88

Miscellaneous

Outstanding Shares
128,160,000
Free Float
125,212,000
Market Cap
$2.82 billion
Optionable
Optionable
Beta
1.90

Social Links

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:SGRY) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners